Eton Pharmaceuticals Reports Fourth Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Eton Pharmaceuticals Inc. (ETON) Tops Q4 EPS by 5c
March 16, 2023 4:02 PM EDTEton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q4 EPS of $0.04, $0.05 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $8.5 million versus the consensus estimate of $8.98 million.
For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) click here.
... More